These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22571612)

  • 21. NMR spectroscopy tools for structure-aided drug design.
    Homans SW
    Angew Chem Int Ed Engl; 2004 Jan; 43(3):290-300. PubMed ID: 14705081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing secondary, tertiary, and quaternary structure along with protein-cofactor interactions for a helical transmembrane protein complex through 1H spin diffusion with MAS NMR spectroscopy.
    Ganapathy S; van Gammeren AJ; Hulsbergen FB; de Groot HJ
    J Am Chem Soc; 2007 Feb; 129(6):1504-5. PubMed ID: 17283988
    [No Abstract]   [Full Text] [Related]  

  • 23. Development and Validation of 2D Difference Intensity Analysis for Chemical Library Screening by Protein-Detected NMR Spectroscopy.
    Egner JM; Jensen DR; Olp MD; Kennedy NW; Volkman BF; Peterson FC; Smith BC; Hill RB
    Chembiochem; 2018 Mar; 19(5):448-458. PubMed ID: 29239081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of cell-free expression and NMR spectroscopy as a new approach for structural investigation of membrane proteins.
    Koglin A; Klammt C; Trbovic N; Schwarz D; Schneider B; Schäfer B; Löhr F; Bernhard F; Dötsch V
    Magn Reson Chem; 2006 Jul; 44 Spec No():S17-23. PubMed ID: 16826540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RAMPED-UP NMR: multiplexed NMR-based screening for drug discovery.
    Zartler ER; Hanson J; Jones BE; Kline AD; Martin G; Mo H; Shapiro MJ; Wang R; Wu H; Yan J
    J Am Chem Soc; 2003 Sep; 125(36):10941-6. PubMed ID: 12952475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMR in drug discovery: A practical guide to identification and validation of ligands interacting with biological macromolecules.
    Gossert AD; Jahnke W
    Prog Nucl Magn Reson Spectrosc; 2016 Nov; 97():82-125. PubMed ID: 27888841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NMR-based screening of membrane protein ligands.
    Yanamala N; Dutta A; Beck B; van Fleet B; Hay K; Yazbak A; Ishima R; Doemling A; Klein-Seetharaman J
    Chem Biol Drug Des; 2010 Mar; 75(3):237-56. PubMed ID: 20331645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand-receptor binding affinities from saturation transfer difference (STD) NMR spectroscopy: the binding isotherm of STD initial growth rates.
    Angulo J; Enríquez-Navas PM; Nieto PM
    Chemistry; 2010 Jul; 16(26):7803-12. PubMed ID: 20496354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective progression of nuclear magnetic resonance-detected fragment hits.
    Eaton HL; Wyss DF
    Methods Enzymol; 2011; 493():447-68. PubMed ID: 21371601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitope mapping and competitive binding of HSA drug site II ligands by NMR diffusion measurements.
    Lucas LH; Price KE; Larive CK
    J Am Chem Soc; 2004 Nov; 126(43):14258-66. PubMed ID: 15506793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear magnetic resonance in target profiling and compound file enhancement.
    Sun C; Hajduk PJ
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):463-70. PubMed ID: 16889229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unraveling complex small-molecule binding mechanisms by using simple NMR spectroscopy.
    Quinternet M; Starck JP; Delsuc MA; Kieffer B
    Chemistry; 2012 Mar; 18(13):3969-74. PubMed ID: 22336999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent developments and applications of saturation transfer difference nuclear magnetic resonance (STD NMR) spectroscopy.
    Wagstaff JL; Taylor SL; Howard MJ
    Mol Biosyst; 2013 Apr; 9(4):571-7. PubMed ID: 23232937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMR spectroscopy: the swiss army knife of drug discovery.
    Horst R; Farley KA; Kormos BL; Withka JM
    J Biomol NMR; 2020 Nov; 74(10-11):509-519. PubMed ID: 32617727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of NMR screening in drug discovery.
    Fejzo J; Lepre C; Xie X
    Curr Top Med Chem; 2003; 3(1):81-97. PubMed ID: 12570779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [NMR-based approach for drug discovery].
    Osawa M; Ikura M
    Tanpakushitsu Kakusan Koso; 2002 Jun; 47(8 Suppl):948-54. PubMed ID: 12099045
    [No Abstract]   [Full Text] [Related]  

  • 37. Solid-state nuclear magnetic resonance spectroscopy for membrane protein structure determination.
    Judge PJ; Taylor GF; Dannatt HR; Watts A
    Methods Mol Biol; 2015; 1261():331-47. PubMed ID: 25502207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Form follows function: shape analysis of protein cavities for receptor-based drug design.
    Weisel M; Proschak E; Kriegl JM; Schneider G
    Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solid-state NMR spectroscopy on complex biomolecules.
    Renault M; Cukkemane A; Baldus M
    Angew Chem Int Ed Engl; 2010 Nov; 49(45):8346-57. PubMed ID: 20941715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TINS, target immobilized NMR screening: an efficient and sensitive method for ligand discovery.
    Vanwetswinkel S; Heetebrij RJ; van Duynhoven J; Hollander JG; Filippov DV; Hajduk PJ; Siegal G
    Chem Biol; 2005 Feb; 12(2):207-16. PubMed ID: 15734648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.